Evidence map›Paper›PMID 40703479›Full record

ArticleFarmaceuticos comunitarios2025

[Pharmaceutical interventions in the new medicine service].

N Amador-Fernández, E L Graham, ShI Benrimoj, E Pérez-Hoyos, V J Baixauli, V Colomer-Molina, O García-Agudo, V García-Cárdenas, M A Gastelurrutia, J Giner-Martínez and 3 more

Abstract readEnglish Abstract
In one paragraph

Article in Farmaceuticos comunitarios, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

N Amador-FernándezGrupo de Investigación en Atención Farmacéutica. Universidad de Granada. España.
E L GrahamGrupo de Investigación en Atención Farmacéutica. Universidad de Granada. España.
ShI BenrimojGrupo de Investigación en Atención Farmacéutica. Universidad de Granada. España.
E Pérez-HoyosUniversidad Tecnológica de Sídney, Sídney Australia.
V J BaixauliSociedad Española de Farmacia Clínica, Familiar y Comunitaria (SEFAC). España.
V Colomer-MolinaMuy Ilustre Colegio Oficial de Farmacéuticos de Valencia (MICOF) España.
O García-AgudoMuy Ilustre Colegio Oficial de Farmacéuticos de Valencia (MICOF) España.
V García-CárdenasGrupo de Investigación en Atención Farmacéutica. Universidad de Granada. España.
M A GastelurrutiaGrupo de Investigación en Atención Farmacéutica. Universidad de Granada. España.
J Giner-MartínezMuy Ilustre Colegio Oficial de Farmacéuticos de Valencia (MICOF) España.
R Palomo-LlinaresDepartamento de Salud Pública e Historia de la Ciencia, Hospital Universitario Sant Joan d'Alacant. España.
R Sánchez-TormoInstituto de Investigación Sanitaria y Biomédica de Alicante (ISABIAL), Alicante. España.
F Martínez-MartínezGrupo de Investigación en Atención Farmacéutica. Universidad de Granada. España.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Community pharmacy has been promoted internationally for the management of minor ailments with positive results for patients and health care systems. This study evaluates the clinical impact and implementation of a minor ailment service in community pharmacies' daily practice. Methods: A pragmatic study with a hybrid effectiveness-implementation design was conducted throughout Spain between 2020-2023. Patients who visited community pharmacies to consult or request a medicine for a minor ailment were included. The intervention consisted of a protocol for the minor ailment service and specific protocols for each ailment agreed with general medical practitioners through the SEFAC eXPERT® IT platform and after community pharmacists' training. Patients were followed up 10 days after the consultation. Results: A total of 430 pharmacies registered 20,987 consultations. 85.2% (n=17,885) were consultations about minor ailments and 14.8% (n=3,102) were requests for specific medications. Minor ailments related to pain (18.7%, n=3,935) were the most frequently consulted. Pharmacists recommended pharmacological treatment to 81.3% (n=17,063) patients and referred 8.0% (n=1,682) patients to a general medical practitioner. 72.4% (n=15,192) of patients responded to follow-up with a symptom resolution of 9.0/10.0, a change in quality of life of +9.0 (0-100 scale) and a satisfaction with the service of 9.6/10. Conclusions: SIF proved to be both operational and effective, yielding beneficial health outcomes. Its implementation enabled the evaluation of a substantial number of consultations and highlighted the need to encourage the routine documentation of services in community pharmacy practice.

Indexed as

Community Pharmacy ServicesAdolescentAdultAgedFemaleHumansMaleMiddle AgedPharmacistsReferral and ConsultationSpainYoung AdultClinical ProtocolsCommunity Pharmacy ServicesImplementation ScienceMinor Ailment ServicePharmaceutical ServicesPharmaciesPrimary Health Care

Identifiers

PMID40703479
PMCPMC12282471

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.